Canton Strategic Holdings, Inc. (CNTN)
NASDAQ: CNTN · Real-Time Price · USD
3.270
+0.190 (6.17%)
At close: Mar 31, 2026, 4:00 PM EDT
3.400
+0.130 (3.98%)
After-hours: Mar 31, 2026, 7:30 PM EDT
Canton Strategic Holdings Market Cap
Canton Strategic Holdings has a market cap or net worth of $168.47 million as of March 31, 2026. Its market cap has increased by 5,908.17% in one year.
Market Cap
168.47M
Enterprise Value
161.05M
1-Year Change
5,908.17%
Ranking
Category
Stock Price
$3.27
Market Cap Chart
Since January 12, 2022, Canton Strategic Holdings's market cap has increased from $32.56M to $168.47M, an increase of 417.36%. That is a compound annual growth rate of 47.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 158.68M | 43.69% |
| Dec 31, 2025 | 110.43M | 2,713.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -86.20% |
| Jan 12, 2022 | 32.56M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 172.79M |
| Tonix Pharmaceuticals Holding | 172.66M |
| Protalix BioTherapeutics | 172.42M |
| Caribou Biosciences | 172.01M |
| Acumen Pharmaceuticals | 163.20M |
| Sagimet Biosciences | 159.34M |
| Tiziana Life Sciences | 158.25M |
| Precision BioSciences | 155.34M |